Source:http://linkedlifedata.com/resource/pubmed/id/18714521
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
30
|
pubmed:dateCreated |
2008-8-21
|
pubmed:abstractText |
To investigate the in vivo mechanism of non-responding to infliximab treatment of patients with rheumatoid arthritis (RA) and the role of anti-infliximab antibodies by using radiolabeled infliximab.
|
pubmed:commentsCorrections | |
pubmed:language |
dut
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0028-2162
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
152
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1672-7
|
pubmed:year |
2008
|
pubmed:articleTitle |
[The formation of infliximab and anti-infliximab immune complexes as an explanation for non-responding to infliximab treatment of rheumatoid arthritis: observational study in 4 patients].
|
pubmed:affiliation |
Afd. Reumatologie, VU Medisch Centrum, Amsterdam. j.vanderlaken@vumc.nl
|
pubmed:publicationType |
Journal Article,
English Abstract
|